N1-Me-Pseudo UTP Sodium Solution - HYJ316
N1-Me-Pseudo UTP Sodium Solution Cat. No. HYJ316

Product Overview

Modified nucleotides are an important part of modern mRNA design, and N1-methylpseudouridine is among the most widely used modifications in mRNA vaccines and therapeutics. The quality of the modified nucleotide feeds directly into the yield and purity of the transcript, so the raw material needs to be consistent from research through commercial production. N1-Me-Pseudo UTP Sodium Solution is a high-purity modified nucleotide raw material designed for in vitro transcription (IVT), mRNA synthesis, and nucleic acid drug development. As a key component for modified mRNA production, it supports the development and manufacturing of mRNA vaccines, gene therapies, and other nucleic acid-based therapeutics, and meets quality requirements from preclinical research to commercial-scale production.

The product is manufactured in a GMP-compliant production environment with a fully animal-origin-free manufacturing process throughout the workflow. Its purity is >99%, and strict quality control gives low impurity levels and ultra-low metal residue content, supporting high-performance mRNA synthesis. Comprehensive quality control systems support excellent batch-to-batch consistency and reliable supply, and DMF filing support is available. N1-Me-Pseudo UTP Sodium Solution is part of a complete portfolio of nucleotide raw materials, and customized specifications and supply solutions can be discussed to meet different manufacturing requirements. The product should be transported frozen below 0°C and stored at -25°C to -15°C to maintain stability and quality.

Product Features

  • High purity with low impurities and ultra-low metal residues: Purity is above 99%, with strict quality control for low impurity levels and ultra-low metal residue content, supporting high-performance mRNA synthesis.
  • GMP-compliant manufacturing with DMF support: The product is produced in a GMP-compliant environment with comprehensive quality control systems, giving excellent batch-to-batch consistency and reliable supply. DMF filing support is available.
  • Animal-origin-free process and flexible supply: The entire manufacturing workflow is animal-origin-free, meeting requirements for advanced therapeutic applications, and customized specifications are available alongside a complete nucleotide portfolio.

FAQ

Q1: What is N1-Me-Pseudo UTP Sodium Solution used for?

It is primarily used as a modified nucleotide substrate for in vitro transcription (IVT) and mRNA synthesis, supporting mRNA vaccine development, gene therapy research and production, and nucleic acid drug R&D and GMP-scale manufacturing.

Q2: Is it suitable for GMP manufacturing, and does the process use animal-derived materials?

The product is manufactured in a GMP-compliant production environment with strict quality control procedures and supports applications from preclinical research to GMP-scale manufacturing. The manufacturing process is completely animal-origin-free, and DMF filing support is available. Please contact us to discuss the documentation you need.

Q3: How should N1-Me-Pseudo UTP Sodium Solution be transported and stored?

It should be transported frozen, below 0°C, and stored at -25°C to -15°C to maintain stability and quality. Customized specifications and supply solutions are available according to your needs.